At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 3 Study Comparing an Ointment Containing Calcipotriol 25 mcg/g Plus Hydrocortisone 10 mg g With Tacalcitol 4 mcg/g Ointment and the Ointment Vehicle Alone, All Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and on the Intertriginous Areas
In Brief
A Phase 3 clinical trial evaluating Calcipotriol plus hydrocortisone ointment vehicle, Tacalcitol Ointment, and 1 other intervention for Psoriasis Vulgaris. Completed, enrolled 782 participants across 3 sites in 3 countries.
Detailed Summary
There are few therapies suitable for the treatment of psoriasis on the face and skin folds. As these areas are sensitive, irritation and other adverse reactions are more common than elsewhere on the body. The purpose of the study is to compare the efficacy and safety of once daily treatment for up to 8 weeks of an ointment containing calcipotriol 25 mcg/g plus hydrocortisone 10 mg/g with tacalcitol 4 mcg/g ointment and the ointment vehicle alone in patients with psoriasis vulgaris on the face and on the intertriginous ares
Study Details
Timeline
Interventions
Once daily application for up to 8 weeks
Once daily application for up to 8 weeks
Once daily application for up to 8 weeks